Literature DB >> 10661567

Isolation of primary and immortalized CD34-hematopoietic and mesenchymal stem cells from various sources.

R Huss1.   

Abstract

Based on historical radiation experiments in rodents, the hematopoietic stem cell was defined by its biological properties and later by the expression of certain surface antigens (e.g., CD34), as well as the absence of lineage-specific markers (e.g., DR). Quite recently it was shown that hematopoietic reconstitution can also be achieved by CD34- stem cells, which can be isolated from the bone marrow, peripheral blood and cord blood cells. CD34-stem cells are considered to be predominately part of the quiescent stem cell pool of hematopoietic and mesenchymal stem cells. Due to novel techniques, CD34-stem cells can be expanded on the level of a true stem cell but also directed towards their differentiation into specified tissues or organ systems. This requires the establishment of primary fibroblast-like CD34- stem cells in vitro and their possible reversible and transient immortalization with optimized vector systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10661567     DOI: 10.1634/stemcells.18-1-1

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  30 in total

Review 1.  Epithelial-mesenchymal transitions and the intersecting cell fate of fibroblasts and metastatic cancer cells.

Authors:  Eric G Neilson; David Plieth; Christo Venkov
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

2.  [Umbilical cord stromal cells (UCSC). Cells featuring osteogenic differentiation potential].

Authors:  M Eblenkamp; J Aigner; J Hintermair; S Potthoff; U Hopfner; V Jacobs; M Niemeyer; E Wintermantel
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

Review 3.  [Embryonic and adult stem cells for tissue engineering in urology].

Authors:  G Bartsch; D Frimberger
Journal:  Urologe A       Date:  2004-10       Impact factor: 0.639

Review 4.  Peripheral blood stem cells: phenotypic diversity and potential clinical applications.

Authors:  Yichi Zhang; Bing Huang
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 5.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

Review 6.  [Cell-based strategies for salivary gland regeneration].

Authors:  N Rotter; C Wirz; J Oder; B Wollenberg; R Huss; S Brandau; S Lang; M Bücheler
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

7.  Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.

Authors:  Jorge F Coelho; Paula C Ferreira; Patricia Alves; Rosemeyre Cordeiro; Ana C Fonseca; Joana R Góis; Maria H Gil
Journal:  EPMA J       Date:  2010-04-10       Impact factor: 6.543

8.  Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Authors:  Masayuki Iwano; David Plieth; Theodore M Danoff; Chengsen Xue; Hirokazu Okada; Eric G Neilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 9.  Is CD34 truly a negative marker for mesenchymal stromal cells?

Authors:  Ching-Shwun Lin; Hongxiu Ning; Guiting Lin; Tom F Lue
Journal:  Cytotherapy       Date:  2012-11       Impact factor: 5.414

10.  Participation of adult mouse bone marrow cells in reconstitution of skin.

Authors:  Ken Kataoka; Reinhold J Medina; Tomofumi Kageyama; Masahiro Miyazaki; Tadashi Yoshino; Teruhiko Makino; Nam-Ho Huh
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.